+49 711 500 989 80
deen

Engineered nanomaterial captures off-target cancer drug to prevent tissue damage



Engineered nanomaterial captures off-target cancer drug to prevent tissue damage

Standard chemotherapies may efficiently kill cancer cells, but they also pose significant risks to healthy cells, resulting in secondary illness and a diminished quality of life for patients. To prevent the previously unavoidable damage, researchers have developed a new class of nanomaterials engineered to capture chemotherapy drugs before they interact with healthy tissue.

Materials provided by Penn State. Original written by Ashley Wenners Herron. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

30th June 2022

Shining some light on the obscure proteome

Read more
29th June 2022

Dynamic cells linked to brain tumor growth and recurrence

Read more
29th June 2022

Scientists discover mechanism controlling spread of pancreatic cancer

Read more